UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19

Therapeutic drug monitoring, 2023-04, Vol.45 (2), p.191-199

2023

Volltextzugriff (PDF)

Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation

British journal of clinical pharmacology, 2017-12, Vol.83 (12), p.2636-2650

2017

Volltextzugriff (PDF)

Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining procedures

Clinica chimica acta, 2024-07, Vol.561, p.119822, Article 119822

2024

Volltextzugriff (PDF)

Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation

Expert review of clinical pharmacology, 2021-12, Vol.14 (12), p.1467-1479

2021

Volltextzugriff (PDF)

A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection

Frontiers in immunology, 2023-05, Vol.14, p.1196882-1196882

2023

Volltextzugriff (PDF)

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Therapeutic drug monitoring, 2021-04, Vol.43 (2), p.150-200

2021

Volltextzugriff (PDF)

Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients

Liver international, 2020-04, Vol.40 (4), p.931-946

2020

Volltextzugriff (PDF)

Monitoring of gene expression in tacrolimus‐treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study

British journal of clinical pharmacology, 2021-10, Vol.87 (10), p.3851-3862

2021

Volltextzugriff (PDF)

MicroRNAs 155‐5p, 122‐5p, and 181a‐5p Identify Patients With Graft Dysfunction Due to T Cell–Mediated Rejection After Liver Transplantation

Liver transplantation, 2020-10, Vol.26 (10), p.1275-1286

2020

Volltextzugriff (PDF)

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

Journal of antimicrobial chemotherapy, 2022-04, Vol.77 (5), p.1365-1371

2022

Volltextzugriff (PDF)

Pharmacodynamic Monitoring of mTOR Inhibitors

Therapeutic drug monitoring, 2019-04, Vol.41 (2), p.160

2019

Volltextzugriff (PDF)

Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic Study

Journal of vascular and interventional radiology, 2022-07, Vol.33 (7), p.752-761

2022

Volltextzugriff (PDF)

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2093

2023

Volltextzugriff (PDF)

Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran

Journal of inherited metabolic disease, 2021-07, Vol.44 (4), p.961-971

2021

Volltextzugriff (PDF)

Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1117

2024

Volltextzugriff (PDF)

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

Therapeutic drug monitoring, 2016-04, Vol.38 (2), p.170-189

2016

Volltextzugriff (PDF)

Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3619-3624

2020

Volltextzugriff (PDF)

Dipentylone: a novel synthetic cathinone in Spain's illicit drug landscape. Findings in a clinical toxicology laboratory

Clinical toxicology (Philadelphia, Pa.), 2024-03, Vol.62 (3), p.209-211

2024

Volltextzugriff (PDF)

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

Therapeutic drug monitoring, 2009-04, Vol.31 (2), p.139-152

2009

Volltextzugriff (PDF)

Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions

Advances in laboratory medicine, 2023-12, Vol.4 (4), p.341-352

2023

Volltextzugriff (PDF)

Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation

Clinical immunology (Orlando, Fla.), 2021-08, Vol.229, p.108792, Article 108792

2021

Volltextzugriff (PDF)

Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel

Therapeutic drug monitoring, 2020-10, Vol.42 (5), p.665-670

2020

Volltextzugriff (PDF)

A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours

European journal of cancer (1990), 2021-03, Vol.146, p.87-94

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

Therapeutic drug monitoring, 2016-04, Vol.38 (2), p.143-169

2016

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(159)
Bücher
(1)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(123)
Humans
(92)
Male
(51)
Female
(47)
Pharmacology & Pharmacy
(44)
Middle Aged
(42)
Adult
(36)
Immunology
(35)
Infectious Diseases
(32)
Microbiology
(29)
Transplantation
(29)
Aged
(28)
Biological And Medical Sciences
(26)
Medical Sciences
(25)
Biomarkers
(21)
Medical Laboratory Technology
(21)
Surgery
(21)
Toxicology
(19)
Immunosuppressive Agents - Therapeutic Use
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19

Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation

Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining procedures

Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation

A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients

Monitoring of gene expression in tacrolimus‐treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study

MicroRNAs 155‐5p, 122‐5p, and 181a‐5p Identify Patients With Graft Dysfunction Due to T Cell–Mediated Rejection After Liver Transplantation

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

Pharmacodynamic Monitoring of mTOR Inhibitors

Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic Study

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients

Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran

Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections

Dipentylone: a novel synthetic cathinone in Spain's illicit drug landscape. Findings in a clinical toxicology laboratory

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions

Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation

Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel

A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

Suchergebnisse filtern